These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 19430174)

  • 1. Larger dosage required for everolimus than sirolimus to maintain same blood concentration in two pancreatic islet transplant patients with tacrolimus.
    Sato E; Yano I; Shimomura M; Masuda S; Katsura T; Matsumoto S; Okitsu T; Iwanaga Y; Uemoto S; Inui K
    Drug Metab Pharmacokinet; 2009; 24(2):175-9. PubMed ID: 19430174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid chromatography-tandem mass spectrometry outperforms fluorescence polarization immunoassay in monitoring everolimus therapy in renal transplantation.
    Moes DJ; Press RR; de Fijter JW; Guchelaar HJ; den Hartigh J
    Ther Drug Monit; 2010 Aug; 32(4):413-9. PubMed ID: 20535052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between everolimus blood concentration assessed using the Innofluor Certican Fluorescence Polarization Immunoassay and the Architect i System sirolimus chemiluminescent microparticle immunoassay.
    Coentrão L; Carvalho C; Sampaio S; Oliveira JG; Pestana MI
    Transplant Proc; 2010 Jun; 42(5):1867-9. PubMed ID: 20620539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of fluorescent polarization immunoassay (FPIA) versus HPLC to measure everolimus blood concentrations in clinical transplantation.
    Khoschsorur G; Fruehwirth F; Zelzer S; Stettin M; Halwachs-Baumann G
    Clin Chim Acta; 2007 May; 380(1-2):217-21. PubMed ID: 17320846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the Innofluor certican assay with HPLC-UV for the determination of everolimus concentrations in heart transplantation.
    Baldelli S; Crippa A; Gabrieli R; Fiocchi R; Perico N; Merlini S; Ottomano C; Cattaneo D
    Clin Biochem; 2006 Dec; 39(12):1152-9. PubMed ID: 17054930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a fluorescent polarization immunoassay for whole blood everolimus determination using samples from renal transplant recipients.
    Salm P; Warnholtz C; Boyd J; Arabshahi L; Marbach P; Taylor PJ
    Clin Biochem; 2006 Jul; 39(7):732-8. PubMed ID: 16725133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of blood sirolimus concentrations in liver and kidney transplant recipients using the Innofluor fluorescence polarization immunoassay: comparison with the microparticle enzyme immunoassay and high-performance liquid chromatography-ultraviolet method.
    Bouzas L; Hermida J; Tutor JC
    Ups J Med Sci; 2009; 114(1):55-61. PubMed ID: 19242874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of sirolimus and everolimus by immunoassay techniques: test specificity and cross-reactivity evaluation.
    Pieri M; Miraglia N; Gentile A; Polichetti G; Castiglia L; Federico S; Sabbatini M; Basile V; Tarantino G; Acampora A; Capone D
    Int J Immunopathol Pharmacol; 2008; 21(3):585-94. PubMed ID: 18831925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Robust, high-throughput LC-MS/MS method for therapeutic drug monitoring of cyclosporine, tacrolimus, everolimus, and sirolimus in whole blood.
    Koster RA; Dijkers EC; Uges DR
    Ther Drug Monit; 2009 Feb; 31(1):116-25. PubMed ID: 19065123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between a liquid chromatography-tandem mass spectrometry assay and a fluorescent polarization immunoassay to measure whole blood everolimus concentration in heart and renal transplantations.
    Dailly E; Deslandes G; Hourmant M; Petit T; Renaud C; Treilhaud M; Jolliet P
    J Clin Lab Anal; 2008; 22(4):282-5. PubMed ID: 18623123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fast LC-MS/MS analysis of tacrolimus, sirolimus, everolimus and cyclosporin A in dried blood spots and the influence of the hematocrit and immunosuppressant concentration on recovery.
    Koster RA; Alffenaar JW; Greijdanus B; Uges DR
    Talanta; 2013 Oct; 115():47-54. PubMed ID: 24054560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of sirolimus and everolimus measured by immunoassay techniques in whole blood samples from kidney transplant patients.
    Capone D; Gentile A; Polichetti G; Federico S; Sabbatini M; Acampora A; Basile V; Pieri M; Tarantino G
    Int J Immunopathol Pharmacol; 2008; 21(2):297-307. PubMed ID: 18547473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procedure for determination of immunosuppressive drugs in whole blood with liquid chromatography-isotope dilution mass spectrometry.
    Molnár PM; Dux L; Reinauer H; Kress M; Akerboom T; Szederkényi E; Kaiser P
    Clin Lab; 2011; 57(11-12):983-92. PubMed ID: 22239031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of blood sirolimus, tacrolimus and everolimus concentrations measured by LC-MS/MS, HPLC-UV and immunoassay methods.
    Sallustio BC; Noll BD; Morris RG
    Clin Biochem; 2011 Feb; 44(2-3):231-6. PubMed ID: 20970416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salting Out-Assisted Liquid-Liquid Extraction for Liquid Chromatography-Tandem Mass Spectrometry Measurement of Tacrolimus, Sirolimus, Everolimus, and Cyclosporine a in Whole Blood.
    Kvamsøe MM; Hansen KR; Skadberg Ø; Vethe NT; Brede C
    Ther Drug Monit; 2020 Oct; 42(5):695-701. PubMed ID: 32701594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two rapid ultra performance liquid chromatography/tandem mass spectrometry (UPLC/MS/MS) methods with common sample pretreatment for therapeutic drug monitoring of immunosuppressants compared to immunoassay.
    Tszyrsznic W; Borowiec A; Pawlowska E; Jazwiec R; Zochowska D; Bartlomiejczyk I; Zegarska J; Paczek L; Dadlez M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Jun; 928():9-15. PubMed ID: 23584041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid liquid chromatography-tandem mass spectrometry routine method for simultaneous determination of sirolimus, everolimus, tacrolimus, and cyclosporin A in whole blood.
    Streit F; Armstrong VW; Oellerich M
    Clin Chem; 2002 Jun; 48(6 Pt 1):955-8. PubMed ID: 12029019
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of a novel commercial assay for the determination of cyclosporine A, tacrolimus, sirolimus, and everolimus by liquid chromatography-tandem mass spectrometric assay.
    Becker S; Thiery J; Ceglarek U
    Ther Drug Monit; 2013 Feb; 35(1):129-32. PubMed ID: 23188181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analytical performance of QMS everolimus assay on ortho Vitros 5,1 FS fusion analyzer: measuring everolimus trough levels for solid organ transplant recipients.
    Shu I; Wright AM; Chandler WL; Bernard DW; Wang P
    Ther Drug Monit; 2014 Apr; 36(2):264-8. PubMed ID: 24232125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An isotope dilution LC-MS/MS based candidate reference method for the quantification of cyclosporine A, tacrolimus, sirolimus and everolimus in human whole blood.
    Taibon J; van Rooij M; Schmid R; Singh N; Albrecht E; Anne Wright J; Geletneky C; Schuster C; Mörlein S; Vogeser M; Seger C; Pongratz S; Kobold U
    Clin Biochem; 2020 Aug; 82():73-84. PubMed ID: 31770523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.